These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 16491268

  • 1. Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients.
    Doumas M, Tsakiris A, Douma S, Grigorakis A, Papadopoulos A, Hounta A, Tsiodras S, Dimitriou D, Giamarellou H.
    Asian J Androl; 2006 Mar; 8(2):177-82. PubMed ID: 16491268
    [Abstract] [Full Text] [Related]

  • 2. Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol.
    Yilmaz MB, Erdem A, Yalta K, Turgut OO, Yilmaz A, Tandogan I.
    Adv Ther; 2008 Sep; 25(9):871-83. PubMed ID: 18758699
    [Abstract] [Full Text] [Related]

  • 3. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW.
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [Abstract] [Full Text] [Related]

  • 4. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men.
    Brixius K, Middeke M, Lichtenthal A, Jahn E, Schwinger RH.
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):327-31. PubMed ID: 17324145
    [Abstract] [Full Text] [Related]

  • 5. Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents.
    Cordero A, Bertomeu-Martínez V, Mazón P, Fácila L, Bertomeu-González V, Conthe P, González-Juanatey JR.
    Cardiovasc Ther; 2010 Apr; 28(1):15-22. PubMed ID: 20074255
    [Abstract] [Full Text] [Related]

  • 6. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
    Oğuz A, Uzunlulu M, Yorulmaz E, Yalçin Y, Hekim N, Fici F.
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):383-7. PubMed ID: 18065333
    [Abstract] [Full Text] [Related]

  • 7. [Nebivolol, a beta blocker of the 3rd generation: modern therapy of arterial hypertension. Results of a multicenter observation study].
    von Fallois J, Faulhaber HD.
    Praxis (Bern 1994); 2001 Mar 15; 90(11):435-41. PubMed ID: 11293936
    [Abstract] [Full Text] [Related]

  • 8. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA.
    Am J Hypertens; 2005 Dec 15; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [Abstract] [Full Text] [Related]

  • 9. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J, Faülhaber HD.
    Fortschr Med Orig; 2000 Jul 27; 118 Suppl 2():77-82. PubMed ID: 15700490
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of nebivolol and atenolol on transmitral diastolic filling parameters in patients with essential hypertension.
    Tuncer M, Guntekin U, Gunes Y, Gumrukcuoglu HA, Eryonucu B.
    Adv Ther; 2008 Jun 27; 25(6):619-26. PubMed ID: 18563311
    [Abstract] [Full Text] [Related]

  • 11. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
    Wolf SC, Buck-Müller N, Görner S, Risler T, Brehm BR.
    Med Klin (Munich); 2003 Jan 15; 98(1):1-6. PubMed ID: 12540987
    [Abstract] [Full Text] [Related]

  • 12. Beta-blockers in the management of hypertension: focus on nebivolol.
    Wojciechowski D, Papademetriou V.
    Expert Rev Cardiovasc Ther; 2008 Apr 15; 6(4):471-9. PubMed ID: 18402537
    [Abstract] [Full Text] [Related]

  • 13. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
    Schellenberg R, Lichtenthal A, Wöhling H, Graf C, Brixius K.
    Headache; 2008 Jan 15; 48(1):118-25. PubMed ID: 18184294
    [Abstract] [Full Text] [Related]

  • 14. Nationwide efficacy-safety study of nebivolol in mildly hypertensive patients.
    Cleophas TJ, Agrawal R, Lichtenthal A, Mäkel W, Fici F.
    Am J Ther; 2006 Jan 15; 13(3):192-7. PubMed ID: 16772759
    [Abstract] [Full Text] [Related]

  • 15. Comparison of Nebivolol monotherapy versus Nebivolol in combination with other antihypertensive therapies for the treatment of hypertension.
    Papademetriou V.
    Am J Cardiol; 2009 Jan 15; 103(2):273-8. PubMed ID: 19121451
    [Abstract] [Full Text] [Related]

  • 16. Nebivolol: new therapy update.
    Sule SS, Frishman W.
    Cardiol Rev; 2006 Jan 15; 14(5):259-64. PubMed ID: 16924166
    [Abstract] [Full Text] [Related]

  • 17. Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients.
    Celik T, Iyisoy A, Kursaklioglu H, Kardesoglu E, Kilic S, Turhan H, Yilmaz MI, Ozcan O, Yaman H, Isik E, Fici F.
    J Hypertens; 2006 Mar 15; 24(3):591-6. PubMed ID: 16467663
    [Abstract] [Full Text] [Related]

  • 18. Nitric oxide mechanisms of nebivolol.
    Maffei A, Lembo G.
    Ther Adv Cardiovasc Dis; 2009 Aug 15; 3(4):317-27. PubMed ID: 19443516
    [Abstract] [Full Text] [Related]

  • 19. Effects of the systemic beta-adrenoceptor antagonist nebivolol on ocular hemodynamics in glaucoma patients.
    Zeitz O, Galambos P, Matthiesen N, Wagenfeld L, Schillinger W, Wiermann A, Richard G, Klemm M.
    Med Sci Monit; 2008 May 15; 14(5):CR268-275. PubMed ID: 18443551
    [Abstract] [Full Text] [Related]

  • 20. Nebivolol induces eNOS activation and NO-liberation in murine corpus cavernosum.
    Reidenbach C, Schwinger RH, Steinritz D, Kehe K, Thiermann H, Klotz T, Sommer F, Bloch W, Brixius K.
    Life Sci; 2007 Jun 06; 80(26):2421-7. PubMed ID: 17512554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.